UNCY SCHEDULE 13G/A: SEC filing

Vivo Opportunity Fund Holdings, L.P. and affiliated entities

Filed with the SEC on · accession 0001213900-26-120151

UNCY filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 16, 2026. Vivo Opportunity Fund Holdings, L.P. and affiliated entities filed an amended Schedule 13G reporting beneficial ownership of approximately 3,911,375 shares of Unicycive Therapeutics common stock (9.99% of the class), consisting of shares issuable upon conversion of Series A-3, A-4, and A-5… The stock moved +4.2% by the first close after the filing.

Summary of the filing

Vivo Opportunity Fund Holdings, L.P. and affiliated entities filed an amended Schedule 13G reporting beneficial ownership of approximately 3,911,375 shares of Unicycive Therapeutics common stock (9.99% of the class), consisting of shares issuable upon conversion of Series A-3, A-4, and A-5 convertible preferred stock underlying warrants. The filing is a passive ownership disclosure under Rule 13d-1(c).

Key details

Shares of common stock beneficially owned by Vivo Opportunity Fund Holdings, L.P. (as reported, including shares issuable upon conversion of preferred stock underlying warrants)$3.9M
Shares of common stock beneficially owned by Vivo Opportunity Cayman Fund, L.P. (as reported, including shares issuable upon conversion of preferred stock underlying warrants)$395K
Reporting person / beneficial ownerVivo Opportunity Fund Holdings, L.P.
General partner of vivo opportunity fund holdings, l.p.Vivo Opportunity, LLC
Reporting person / beneficial ownerVivo Opportunity Cayman Fund, L.P.
General partner of vivo opportunity cayman fund, l.p.Vivo Opportunity Cayman, LLC
IssuerUnicycive Therapeutics, Inc.

How UNCY stock reacted

Close before

$3.55

Nov 13, 2026

First close after

+4.23%

$3.70

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for UNCY, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for UNCY?

Click here

Frequently asked questions

What did UNCY file with the SEC on Nov 16, 2026?

UNCY filed a SCHEDULE 13G/A (SEC filing). Vivo Opportunity Fund Holdings, L.P. and affiliated entities filed an amended Schedule 13G reporting beneficial ownership of approximately 3,911,375 shares of Unicycive Therapeutics common stock (9.99% of the class), consisting of shares issuable upon conversion of Series A-3, A-4, and A-5 convertible preferred stock underlying warrants. The filing is a passive ownership disclosure under Rule 13d-1(c).

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

How did UNCY stock react to this filing?

UNCY closed at $3.55 before the filing and $3.70 on Nov 16, 2026 (+4.23%).

Other UNCY SEC filings

Get alerts when UNCY files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days